These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11728346)

  • 21. Long-term effects of diltiazem and verapamil on mortality and cardiac events in non-Q-wave acute myocardial infarction without pulmonary congestion: post hoc subset analysis of the multicenter diltiazem postinfarction trial and the second danish verapamil infarction trial studies.
    Gibson RS; Hansen JF; Messerli F; Schechtman KB; Boden WE
    Am J Cardiol; 2000 Aug; 86(3):275-9. PubMed ID: 10922432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic usefulness of white blood cell count on admission and one-year outcome in patients with non-ST-segment elevation acute chest pain.
    Sanchis J; Bodí V; Núñez J; Bertomeu V; Consuegra L; Bosch MJ; Gómez C; Bosch X; Chorro FJ; Llácer A
    Am J Cardiol; 2006 Oct; 98(7):885-9. PubMed ID: 16996867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proenkephalin and prognosis after acute myocardial infarction.
    Ng LL; Sandhu JK; Narayan H; Quinn PA; Squire IB; Davies JE; Bergmann A; Maisel A; Jones DJ
    J Am Coll Cardiol; 2014 Jan; 63(3):280-9. PubMed ID: 24140658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diltiazem in acute myocardial infarction treated with thrombolytic agents: a randomised placebo-controlled trial. Incomplete Infarction Trial of European Research Collaborators Evaluating Prognosis post-Thrombolysis (INTERCEPT).
    Boden WE; van Gilst WH; Scheldewaert RG; Starkey IR; Carlier MF; Julian DG; Whitehead A; Bertrand ME; Col JJ; Pedersen OL; Lie KI; Santoni JP; Fox KM
    Lancet; 2000 May; 355(9217):1751-6. PubMed ID: 10832825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Usefulness of high-sensitivity C-reactive protein in predicting long-term risk of death or acute myocardial infarction in patients with unstable or stable angina pectoris or acute myocardial infarction.
    Zebrack JS; Anderson JL; Maycock CA; Horne BD; Bair TL; Muhlestein JB;
    Am J Cardiol; 2002 Jan; 89(2):145-9. PubMed ID: 11792332
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of ten-year event-free survival in patients with acute myocardial infarction (from the Adria, Bassano, Conegliano, and Padova Hospitals [ABC] study on myocardial infarction).
    Berton G; Cordiano R; Cavuto F; Giacomini G; De Toni R; Palatini P
    Am J Cardiol; 2012 Apr; 109(7):966-75. PubMed ID: 22221943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between elevated left ventricular mass index and increased cardiovascular events in patients with acute coronary syndrome: A sub-analysis of the HIJ-PROPER study.
    Sone M; Saito C; Arashi H; Yamaguchi J; Ogawa H; Hagiwara N
    Echocardiography; 2021 Sep; 38(9):1567-1573. PubMed ID: 34346521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Biohemorheologic factors and cardiovascular events curve in survivors of transmural acute myocardial infarct--24-month follow-up].
    Sargento L; do Rosário HS; Perdigão C; Monteiro J; Saldanha C; e Silva JM
    Rev Port Cardiol; 2002 Feb; 21(2):165-71. PubMed ID: 11963286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Leukocyte count and vascular risk in symptomatic intracranial atherosclerosis.
    Ovbiagele B; Lynn MJ; Saver JL; Chimowitz MI;
    Cerebrovasc Dis; 2007; 24(2-3):283-8. PubMed ID: 17646693
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Baseline SYNTAX score and long-term outcome in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Akgun T; Oduncu V; Bitigen A; Karabay CY; Erkol A; Kocabay G; Ozveren O; Yildiz A; Cimen AO; Kirma C
    Clin Appl Thromb Hemost; 2015 Nov; 21(8):712-9. PubMed ID: 24500763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The early diastolic myocardial velocity: a marker of increased risk in patients with coronary heart disease.
    Johnson J; Manouras A; Bergholm F; Brodin LÅ; Agewall S; Henareh L
    Clin Physiol Funct Imaging; 2014 Sep; 34(5):389-96. PubMed ID: 24438358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute hyperglycaemia and inflammation in patients with ST segment elevation myocardial infarction.
    Terlecki M; Bednarek A; Kawecka-Jaszcz K; Czarnecka D; Bryniarski L
    Kardiol Pol; 2013; 71(3):260-7. PubMed ID: 23575781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is angiotensin-converting enzyme inhibitor useful in a Japanese population for secondary prevention after acute myocardial infarction? A final report of the Japanese Acute Myocardial Infarction Prospective (JAMP) study.
    Ueshima K; Fukami K; Hiramori K; Hosoda S; Kishida H; Kato K; Fujita T; Tsutani K; Sakuma A;
    Am Heart J; 2004 Aug; 148(2):e8. PubMed ID: 15309011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Age-related prognosis after acute myocardial infarction (the Multicenter Diltiazem Postinfarction Trial).
    Marcus FI; Friday K; McCans J; Moon T; Hahn E; Cobb L; Edwards J; Kuller L
    Am J Cardiol; 1990 Mar; 65(9):559-66. PubMed ID: 2178380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma cystatin C for prediction of 1-year cardiac events in Mediterranean patients with non-ST elevation acute coronary syndrome.
    Taglieri N; Fernandez-Berges DJ; Koenig W; Consuegra-Sanchez L; Fernandez JM; Robles NR; Sánchez PL; Beiras AC; Orbe PM; Kaski JC;
    Atherosclerosis; 2010 Mar; 209(1):300-5. PubMed ID: 19819453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vitamin D and prognosis in acute myocardial infarction.
    Ng LL; Sandhu JK; Squire IB; Davies JE; Jones DJ
    Int J Cardiol; 2013 Oct; 168(3):2341-6. PubMed ID: 23415169
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin-6 and the Risk of Adverse Outcomes in Patients After an Acute Coronary Syndrome: Observations From the SOLID-TIMI 52 (Stabilization of Plaque Using Darapladib-Thrombolysis in Myocardial Infarction 52) Trial.
    Fanola CL; Morrow DA; Cannon CP; Jarolim P; Lukas MA; Bode C; Hochman JS; Goodrich EL; Braunwald E; O'Donoghue ML
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29066436
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postinfarction stress testing and one year outcome of stable patients after myocardial infarction treated with thrombolytics.
    Wagner S; Schuster S; Zahn R; Sattler B; Senges J
    Eur J Med Res; 1996 Nov; 1(12):575-81. PubMed ID: 9438166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coronary intervention for persistent occlusion after myocardial infarction.
    Hochman JS; Lamas GA; Buller CE; Dzavik V; Reynolds HR; Abramsky SJ; Forman S; Ruzyllo W; Maggioni AP; White H; Sadowski Z; Carvalho AC; Rankin JM; Renkin JP; Steg PG; Mascette AM; Sopko G; Pfisterer ME; Leor J; Fridrich V; Mark DB; Knatterud GL;
    N Engl J Med; 2006 Dec; 355(23):2395-407. PubMed ID: 17105759
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of oral beta-blocker therapy on mortality after primary percutaneous coronary intervention for Killip class 1 myocardial infarction.
    Hioki H; Motoki H; Izawa A; Kashima Y; Miura T; Ebisawa S; Tomita T; Miyashita Y; Koyama J; Ikeda U
    Heart Vessels; 2016 May; 31(5):687-93. PubMed ID: 25863805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.